NewAmsterdam Pharma N.V. (NAMSW)
undefined
undefined%
At close: undefined
13.02
-3.41%
After-hours Dec 13, 2024, 03:03 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 340.45M 438.52M 53.09M 7.86M
Short-Term Investments - - - -
Long-Term Investments - - 718.35K 112.79M
Other Long-Term Assets 35.00K 146.00K -353 -112.79M
Receivables 1.88M 2.07M 4.86M -
Inventory - 21.50K -735 -
Other Current Assets 4.46M 8.18M 7.47M 1.67M
Total Current Assets 346.79M 448.13M 58.87M 9.22M
Property-Plant & Equipment 101.00K 144.00K 190.00K 12.00K
Goodwill & Intangibles 170.00K 83.16M - -
Total Long-Term Assets 306.00K 83.45M 908.00K 12.00K
Total Assets 347.10M 531.58M 59.78M 9.23M
Account Payables 16.92M 11.85M 7.04M 487.06K
Deferred Revenue 8.94M 13.01M 3.61M -
Short-Term Debt 60.00K 66.00K 60.01K 11.65M
Other Current Liabilities 23.97M 9.67M 1.31M 670.94K
Total Current Liabilities 49.90M 35.46M 9.88M 12.81M
Long-Term Debt - 60.00K 125.68K -
Other Long-Term Liabilities 7.79M 6.75M -14.68K -
Total Long-Term Liabilities 8.81M 11.60M 111.00K 9.95M
Total Liabilities 58.70M 47.06M 9.99M 12.81M
Total Debt 60.00K 118.00K 164.00K 11.65M
Common Stock 10.17M 599.19M 83.88M 2.50M
Retained Earnings -316.97M -119.36M -34.68M -6.08M
Comprehensive Income 4.42M 4.69M 591.00K -
Shareholders Equity 288.39M 484.52M 49.79M -3.58M
Total Investments -31.08M - 718.35K 112.79M